ArticleEuropean journal of clinical pharmacology2026

Patient overlap and the validity of SGLT2 inhibitor benefits after TAVI: a critique of recent meta-analytical findings.

Ahmed Adel MohamedPubMed ↗Publisher ↗

No numbers read from the abstract.